| Brand Name | Tasso |
| Packaging Type | Bottle |
| Molecule | Osimertinib |
| Generic Name | Osimertinib 80mg |
| Manufactured By | Jenphar Bangladesh |
| Quantity | 30 Tablets |
| Form | Tablets |
| Country of Origin | Bangladesh |
| Categories | Oncology |
Introduction to Tasso 80mg Tablet
Tasso 80mg, manufactured by Jenphar Bangladesh, contains Osimertinib, a third-generation EGFR tyrosine kinase inhibitor. It is used to treat non-small cell lung cancer (NSCLC) in patients with specific mutations in the epidermal growth factor receptor (EGFR). Tasso Osimertinib 80mg tablet helps block the abnormal proteins that drive cancer cell growth, slowing or stopping the spread of cancer, particularly in advanced or metastatic NSCLC with EGFR mutations.
This medication is typically prescribed as a first-line treatment or for patients whose cancer has become resistant to earlier treatments. Always take Tasso 80mg as directed by your healthcare provider.
Osimertinib 80 mg is used to treat non-small cell lung cancer (NSCLC) with specific EGFR mutations.
Common side effects of Osimertinib include diarrhea, rash, dry skin, nail toxicity, and fatigue.
No, Tagrisso is not safe during pregnancy or breastfeeding. Use birth control while taking Tagrisso and for several weeks after your last dose.
Generic Tagrisso is not a cure for lung cancer, but it can significantly extend survival and delay disease progression in patients with advanced non-small cell lung cancer (NSCLC) with specific EGFR mutations.
No, Tagrisso is neither chemotherapy nor immunotherapy. It is a targeted therapy specifically designed to inhibit mutated EGFR in certain types of lung cancer.
Generic Tagrisso works by inhibiting the activity of mutated EGFR, which is responsible for the growth of certain types of non-small cell lung cancer. By blocking this pathway, the drug prevents cancer cells from growing and spreading.
Yes, Tagrisso works by targeting and killing cancer cells that have specific EGFR mutations, inhibiting their growth and spread in non-small cell lung cancer (NSCLC).
If you miss a dose, skip the missed dose and take your next dose at the regular time. Do not take two doses at once to make up for the missed dose.
No, Osimertinib (Tagrisso) is a prescription medication, and you need a doctor’s prescription to obtain it.
You can order Osimertinib by logging into your account on our website, adding the tablet to your cart, and proceeding to checkout. After successful payment, your order will be confirmed, and you will receive a confirmation email. You can also contact us via WhatsApp to place your order directly.
